Here are five notes:
1. The CASCADE trial compared spinal fusion between its composite silicon nitride fusion devices with a central, cancellous ceramic core, to the industry standard of PEEK spacers filled with bone autograft.
2. Mark P. Arts, MD, PhD, principal investigator and neurosurgeon from the Medical Center Haaglanded in the Netherlands, will present the data.
3. B. Sonny Bal, MD, chairman and CEO of Amedica, will discuss the trial results impact on the business.
4. The webcast will take place on Mon., March 7, at 2:00 pm EST and can be viewed on Amedica’s website.
5. Amedica is a company focused on the development and application of interbody implants manufactured with medical-grade silicon nitride ceramic.
More articles on devices and implants:
Profit Investment Management decreases position in NuVasive by 35.6%: 4 points
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know
EOS imaging receives innovative technology status from South Korean entity: 3 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
